Nanotechnology and In Silico Tools

Dr. Mital J. Kaneria has received his M.Sc. and Ph.D. degree in Plant Science. During his Ph.D., he was awarded a BSR Fellowship from UGC, India, for three years and later awarded young scientist award by DST-SERB to participate in an international conference at Institute of Pasture, Paris, France. He has published more than 65 research articles in journals, book chapters and conference proceedings, with notable citation indices. He is a reviewer and editorial board member of many journals, member of many scientific societies, has presented number of papers in conferences and received best paper awards, as well as recently filed one patent. Working as Assistant Professor in the Department of Biosciences, Saurashtra University, India, since 2012. He is working in the field of medicinal plants, herbal technology, pharmacology and drug discovery since more than 14 years. His doctoral research was based on the phytochemical and pharmacological potency of a selected medicinal plant from Gujarat region. His group is working on various aspects of phytochemistry, metabolomics, anti-ageing, drug discovery and designing. Dr. Kalpna D. Rakholiya has received her M.Sc., M.Phil. and Ph.D. degree in Microbiology. During her Ph.D., she was awarded UGC-MRP Fellowship and later awarded National Post Doctoral fellowship by DST-SERB. She has published more than 50 research articles in journals, book chapters and conference proceedings, with good citation score. She is a reviewer and editorial board member of many journals, member of many scientific societies, has presented number of papers in conferences and received best paper awards, as well as recently filed one patent in the area of PGPR. Presently, working as Assistant Professor and Head of the Microbiology Department, Harivandana College, Rajkot, India. She is working in the field of antimicrobials and antioxidants from medicinal plant and other sources, biocontrols and host-microbe interactions since more than 14 years. Her doctoral research was based on the antimicrobial and antioxidant properties of different parts of Kesar Mango. Currently her group is working on various aspects of exometabolomics, PGPR, antimicrobics and drug discovery.

Part: I Nanotechnology 1. Green route synthesis of silver nanoparticles (Ag-NPs) and their applications 2. Biological synthesis of nanoparticles: a value of ethnomedicine 3. Recent trends of viral nanotechnology: an overview 4. Biological synthesis of nanoparticles from selected medicinal plants 5. Green synthesis of silver nanoparticles, characterization techniques and biological activities 6. Synergistic effects of plant extracts and nanoparticles for therapy 7. Biogenically efficient production and characterization of silver nanoparticles using the marine fungus Hamigera terricola along with their antimicrobial and antioxidative efficacy 8. Green synthesis of silver nanoparticles and their potenial biological applications 9. Green synthesis of silver nanoparticles, characterization and their biological efficacy 10. Evaluation of antimicrobial, antioxidant, and photocatalytic activity of zinc oxide nanoparticles synthesized from Parmotrema perlatum 12. A comprehensive review on eco-friendly synthesized gold nanoparticles and its advantages 13. Green synthesis of nanoparticles from Catharantus roseus and study of its therapeutical applications 14. Supercritical solvent-assisted green isolation of naturally occurring therapeutically active nanomaterialda review Part II In silico tools and techniques 15. In silico studies of phytochemicals of antiviral plants against human papillomavirus-16 E6 Oncoprotein: potential therapeutic drugs for cervical cancer 16. A computational approach to finding novel drug targets and their natural product inhibitors for Aspergillus flavus 17. Virtual screening of natural product as TAM family of RTK inhibitor: A potential tool for anticancer drug design 18. In silico tools to comprehend legumes derived bioactive peptides in diabetes and hypertension therapeutics 19. Deciphering the scope of in silico screening of novel natural lead molecules against putative molecular targets of multidrug-resistant bacterial pathogens 20. A computational approach to identify natural putative inhibitors to combat monkeypox 21. In silico identification of natural product inhibitor for multidrug resistance proteins from selected gram-positive bacteria 22. Virtual screening and molecular docking for the identification of potential antibreast cancer agents targeting estrogen receptor 23. In silico techniques for screening of key secondary metabolites of medicinal plants 24. Comprehensive resources for ligand-based drug discovery 25. Molecular docking of phytochemicals targeting ER, PR, and HER2 receptors as therapeutic sites for breast cancer: An in silico study 26. In silico identification of novel drug target and its natural product inhibitors for herpes simplex virus